SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (5902)3/13/2002 9:50:01 PM
From: Sleepman  Respond to of 52153
 
Thanks for the reply. I too had gotten out. . . fortunately at the highs. I am very interested in their Albumen which is going to be in cattle. The ATII should eventually make it to market for congenital deficiency where the current plasma derrived product sells over 100 million annually. I would suspect that they could get a chunk of that.
Another company that is using goats is Nexia. It is a Canadian company who is making spider silk from goats. They are still a little out from marketing a product, but very interesting.
I'll look into the other companies. Thanks again.
Dan



To: Biomaven who wrote (5902)3/14/2002 1:31:38 AM
From: Spekulatius  Respond to of 52153
 
<< I think this is still a stock where I'll give someone else the first double or triple >>.
I agree with you, but if you buy in the 3-3.5$ its valued near cash - GZTC has cooperations with major players and a low enough burn rate that one does not have to worry about financing for a while. In other words, it a great trading sardine for 30-100% returns <g>.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News